Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders.
Hypocholesterolemia has been observed in several inflammatory diseases such as rheumatoid arthritis, myeloproliferative disorders, systemic lupus erythematosus and sarcoidosis. Serum amyloid A is an acute-phase reactant that is related to the high-density lipoprotein cholesterol. This review discusses the relationship between the activation of the cells of the monocyte-macrophage system, determined by the serum amyloid A levels, and the lipid metabolism, measured as alterations in plasma lipoprotein concentrations. The mechanisms of this association during acute inflammation are also discussed in this review.
Salazar
A
A
Internal Medicine Service, Ciutat Sanitària i Universitària de Bellvitge, Consell de Cent 218, 08011 Barcelona, Spain. asalazar@csub.scs.es
Pintó
X
X
Mañá
J
J
D001053:Apolipoproteins / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000276:immunology; D015415:Biomarkers; D008076:Cholesterol, HDL / Q000097:blood*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000276:immunology; D009196:Myeloproliferative Disorders / Q000097:blood / Q000276:immunology; D012507:Sarcoidosis / Q000097:blood* / Q000276:immunology*; D000685:Serum Amyloid A Protein
D001053:Apolipoproteins; D015415:Biomarkers; D008076:Cholesterol, HDL; D000685:Serum Amyloid A Protein